Nichols David E
Division of Chemical Biology and Medicinal Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Front Psychiatry. 2022 Mar 25;13:863088. doi: 10.3389/fpsyt.2022.863088. eCollection 2022.
At first glance, it appears there is little difference between the molecular structures of methylenedioxymethamphetamine (MDMA), which has an -methyl attached to its amino group, and methylenedioxyamphetamine (MDA), a primary amine that is recognized to have hallucinogenic activity. It is known from studies with other hallucinogenic amphetamines that -methylation of hallucinogenic amphetamines attenuates or abolishes hallucinogenic activity. Nevertheless, MDMA is biologically active and has a potency only slightly less than its MDA parent. Importantly, it is the Ievo-isomer of hallucinogenic phenethylamines that is more biologically active, whereas it is the dextro isomer of MDMA that is more active. This reversal of stereochemistry for the activity of two very closely related molecules is a very powerful clue that their mechanisms of action differ. Finally, extension of the alpha-methyl of hallucinogenic amphetamines to an alpha-ethyl moiety completely abolishes their hallucinogenic activity. Ultimately, we extended the alpha-methyl group of MDMA to an alpha-ethyl to afford a molecule we named (N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB) that retained significant MDMA-like psychoactivity. Hence, there are three structural features that distinguish MDMA from the hallucinogenic amphetamines: (1) the -methyl on the basic nitrogen, (2) the reversal of stereochemistry and, (3) tolerance of an alpha-ethyl moiety as contrasted with the alpha-methyl of hallucinogenic phenethylamines. Clearly, MDMA is distinct from classical hallucinogenic phenethylamines in its structure, and its psychopharmacology is also unique. Thus, in 1986 I proposed the name "Entactogen" for the pharmacological class of drugs that includes 3,4-methylenedioxymethamphetamine (MDMA) and other substances with a similar psychopharmacological effect. The name is derived from roots that indicate that entactogens produce a "touching within." Rather than having significant psychostimulant, or hallucinogenic effects, MDMA powerfully promotes affiliative social behavior, has acute anxiolytic effects, and can lead to profound states of introspection and personal reflection. Its mechanism of action is now established as involving transport of MDMA by the neuronal serotonin reuptake carrier followed by carrier-mediated release of stored neuronal serotonin.
乍一看,附着在氨基上带有α-甲基的亚甲基二氧甲基苯丙胺(摇头丸,MDMA)与被认为具有致幻活性的伯胺亚甲基二氧苯丙胺(MDA)的分子结构似乎没有太大区别。从对其他致幻苯丙胺的研究中可知,致幻苯丙胺的α-甲基化会减弱或消除其致幻活性。然而,MDMA具有生物活性,其效力仅略低于其母体MDA。重要的是,致幻苯乙胺的左旋异构体生物活性更强,而MDMA的右旋异构体活性更高。这两种非常密切相关的分子活性的立体化学反转是一个非常有力的线索,表明它们的作用机制不同。最后,将致幻苯丙胺的α-甲基扩展为α-乙基部分会完全消除其致幻活性。最终,我们将MDMA的α-甲基基团扩展为α-乙基,得到了一个我们命名为(N-甲基-1-(1,3-苯并二氧杂环戊烯-5-基)-2-丁胺,MBDB)的分子,它保留了显著的类似MDMA的精神活性。因此,有三个结构特征将MDMA与致幻苯丙胺区分开来:(1)碱性氮上的α-甲基,(2)立体化学的反转,以及(3)与致幻苯乙胺的α-甲基相比,对α-乙基部分的耐受性。显然,MDMA在结构上与经典的致幻苯乙胺不同,其精神药理学也很独特。因此,在1986年,我为包括3,4-亚甲基二氧甲基苯丙胺(MDMA)和其他具有类似精神药理作用的物质的药物类别提出了“触觉致幻剂”这个名称。这个名称来源于一些词根,表明触觉致幻剂会产生一种“内在的触动”。MDMA不是具有显著的精神刺激或致幻作用,而是有力地促进亲和性社会行为,具有急性抗焦虑作用,并可导致深刻的内省和个人反思状态。现在已经确定其作用机制涉及通过神经元5-羟色胺再摄取载体转运MDMA,随后由载体介导释放储存的神经元5-羟色胺。